Exploiting mechanistic differences between drug classes to define functional drug interaction domains on topoisomerase II. Evidence that several diverse DNA cleavage-enhancing agents share a common site of action on the enzyme-Reference-Cited by-同舟云学术

Exploiting mechanistic differences between drug classes to define functional drug interaction domains on topoisomerase II. Evidence that several diverse DNA cleavage-enhancing agents share a common site of action on the enzyme

Published:1993-07 Issue:19 Volume:268 Page:14394-14398
ISSN:0021-9258
Container-title:Journal of Biological Chemistry
language:en
Short-container-title:Journal of Biological Chemistry

Author:

Corbett A.H.,Hong D.,Osheroff N.

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry

Reference34 articles.

1. Annu. Rev. Biochem;Liu,1989

2. Adv. Pharmacol;Schneider,1990

3. BioEssays;Osheroff,1991

4. J. Bacteriol;Kreuzer,1979

5. Proc. Natl. Acad. Sci. U. S. A;Gellert,1976

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anthracyclines induce the accumulation of mutant p53 through E2F1-dependent and -independent mechanisms;Oncogene;2011-03-28

2. Mitotic Phosphorylation Stimulates DNA Relaxation Activity of Human Topoisomerase I;Journal of Biological Chemistry;2008-06

3. Novobiocin induces apoptosis-like cell death in topoisomerase II over-expressing arsenite resistant Leishmania donovani;Molecular and Biochemical Parasitology;2005-05

4. Pharmacological Approaches to Correcting the Ion Transport Defect in Cystic Fibrosis;American Journal of Respiratory Medicine;2003-10

5. Pharmacokinetic scaling of SJ-8029, a novel anticancer agent possessing microtubule and topoisomerase inhibiting activities, by species-invariant time methods;Biopharmaceutics & Drug Disposition;2003